drugset / Trial / NCT01073709

A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fasting Condition

NCT01073709

Completed 40 enrolled Ranbaxy Laboratories Limited
RandomizedCrossoverOpen-label

Summary

The study was conducted as an open labeled, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing acetaminophen extended release gelcaps 650 mg of OHM Laboratories Inc. with Tylenol® Arthritis Pain caplets 650 mg of McNeil Consumer \& Specialty Pharmaceuticals, in healthy, adult, human, male subjects under fasting condition.

Timeline

Start
2007-11
Primary completion
2007-11
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Oral

Indications

No indication recorded.